Skip to main content
. 2020 Mar;1867(3):118471. doi: 10.1016/j.bbamcr.2019.04.001

Table 2.

Disease modeling utilizing hiPSC-CM, restricted to studies describing changes in energy metabolism.

Condition Reported metabolic abnormalities in diseased hiPSC-CM Ref.
Barth syndrome Fragmented mitochondria, elevated basal oxygen consumption rates and impaired electron transport chain [65]
[124]
Pompe disease Degenerated mitochondria, lower oxygen consumption rate, accumulation of glycogen [[125], [126], [127]]
Friedreich's ataxia mtDNA depletion, mitochondria network disorganization and lower level of respiratory chain proteins [128]
Arrhythmogenic right ventricular dysplasia (ARVD) PPARγ over-activation and lipid accumulation; diseased hiPSC-CM directly transdifferentiate into adipocytes [66]
[84]
[[129], [130], [131]]
Danon's disease Reduced mitophagic flux resulted in mitochondrial fragmentation [132]
[134]
Hypertrophic cardiomyopathy Abnormally high metabolic respiration rate [44]